These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 17392933

  • 1. Depression and anxiety: pharmacological treatment in general practice.
    Ellen S, Selzer R, Norman T, Blashki G.
    Aust Fam Physician; 2007 Apr; 36(4):222-8. PubMed ID: 17392933
    [Abstract] [Full Text] [Related]

  • 2. Pharmacotherapy in depressed children and adolescents.
    Taurines R, Gerlach M, Warnke A, Thome J, Wewetzer C.
    World J Biol Psychiatry; 2011 Sep; 12 Suppl 1():11-5. PubMed ID: 21905988
    [Abstract] [Full Text] [Related]

  • 3. [Range of activity of anxiolytic and antidepressant drugs].
    Linkowski P.
    Rev Med Brux; 1996 Sep; 17(4):220-3. PubMed ID: 8927849
    [Abstract] [Full Text] [Related]

  • 4. Treating comorbid depression and anxiety.
    Kuzel RJ.
    J Fam Pract; 1996 Dec; 43(6 Suppl):S45-53. PubMed ID: 8969712
    [Abstract] [Full Text] [Related]

  • 5. [The use of antidepressants to treat depression in children and adolescents].
    Desombre H, Paccalin C, Revol O, Fourneret P.
    Arch Pediatr; 2006 Jun; 13(6):711-3. PubMed ID: 16697608
    [No Abstract] [Full Text] [Related]

  • 6. [Anxiety and depression: which antidepressants treat both at the same time?].
    Laflamme F.
    Perspect Infirm; 2010 Jun; 7(2):43. PubMed ID: 21744603
    [No Abstract] [Full Text] [Related]

  • 7. New developments in the neurobiological basis of anxiety disorders.
    Gorman JM, Hirschfeld RM, Ninan PT.
    Psychopharmacol Bull; 2002 Jun; 36 Suppl 2():49-67. PubMed ID: 12490823
    [Abstract] [Full Text] [Related]

  • 8. Psychopharmaco-hazardology: major hazards of treating depression and anxiety.
    Zetin M.
    Compr Ther; 2004 Jun; 30(1):18-24. PubMed ID: 15162588
    [Abstract] [Full Text] [Related]

  • 9. [Selective serotonin and noradrenaline reuptake inhibitors: a step forward in the treatment of depression?].
    Möller HJ, Bauer M, Fritze J, Haen E, Laux G, Müller WE, Rüther E.
    MMW Fortschr Med; 2005 Jan 20; 147(3):43-5. PubMed ID: 15727113
    [Abstract] [Full Text] [Related]

  • 10. [Psychopharmacology of anxiety and depression: Historical aspects, current treatments and perspectives].
    Javelot H.
    Ann Pharm Fr; 2016 Mar 20; 74(2):93-118. PubMed ID: 26472602
    [Abstract] [Full Text] [Related]

  • 11. Where is the room for improvement in the drug treatment of depression and anxiety?
    Baldwin DS.
    Hum Psychopharmacol; 2011 Jan 20; 26(1):1-3. PubMed ID: 23055413
    [No Abstract] [Full Text] [Related]

  • 12. Selective serotonin reuptake inhibitors in mixed anxiety-depression.
    Berk M.
    Int Clin Psychopharmacol; 2000 Aug 20; 15 Suppl 2():S41-5. PubMed ID: 11110018
    [Abstract] [Full Text] [Related]

  • 13. Sleep patterns in depression and anxiety: theory and pharmacological effects.
    Sandor P, Shapiro CM.
    J Psychosom Res; 1994 Aug 20; 38 Suppl 1():125-39. PubMed ID: 7799244
    [Abstract] [Full Text] [Related]

  • 14. [Which antipsychotic drugs are proper for HIV patients?].
    Holm S, Perro C.
    MMW Fortschr Med; 2010 Apr 29; 152(17):36-8. PubMed ID: 20509258
    [No Abstract] [Full Text] [Related]

  • 15. [Individualized treatment with antidepressants].
    Köhler S, Arndt A, Sterzer P, Bschor T.
    Fortschr Neurol Psychiatr; 2013 Feb 29; 81(2):104-16; quiz 117-8. PubMed ID: 23412962
    [No Abstract] [Full Text] [Related]

  • 16. Mergers and acquisitions among psychotropics: antidepressant takeover of anxiety may now be complete.
    Stahl SM.
    J Clin Psychiatry; 1999 May 29; 60(5):282-3. PubMed ID: 10362433
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of antidepressant drug treatment in children and adolescents.
    Henry A, Kisicki MD, Varley C.
    Mol Psychiatry; 2012 Dec 29; 17(12):1186-93. PubMed ID: 22064376
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological treatment of depression and comorbid anxiety disorders.
    Cassano GB, Michelini S.
    Adv Biochem Psychopharmacol; 1995 Dec 29; 49():113-25. PubMed ID: 7653331
    [No Abstract] [Full Text] [Related]

  • 19. An evidence-based review of the clinical use of sertraline in mood and anxiety disorders.
    Sheehan DV, Kamijima K.
    Int Clin Psychopharmacol; 2009 Mar 29; 24(2):43-60. PubMed ID: 21456103
    [Abstract] [Full Text] [Related]

  • 20. Depression & anxiety: readers reveal the therapists and drugs that helped.
    Consum Rep; 2010 Jul 29; 75(7):28-31. PubMed ID: 20578337
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.